EN
HI
Emcure Pharmaceuticals Chart
Emcure Pharmaceuticals Share Key Metrics
Volume
1.16 L
Market Cap
32916.54 CR
LTQ@LTP
9@1736.20
ATP
1715.93
Var Margin
17.36 %
Circuit Range
1515-1851.6
Delivery %
47.27 %
Value
19.89 CR
ASM/GSM
No
Market Lot
1
Summary
Emcure Pharmaceuticals share price is ₹1736.2 as of 13 Jun, 2026. The stock Emcure Pharmaceuticals intraday movement has stayed between ₹1679.00 and ₹1747.00, while on a 52-week basis,Emcure Pharmaceuticals price 52 week high is ₹1830.00 & its 52 week low is ₹1228.90.
In terms of trading activity, Emcure Pharmaceuticals has recorded a volume of 115903 shares, The Emcure Pharmaceuticals has a market cap of ₹189589547 CR. The stock’s Average Traded Price (ATP) stands at ₹1715.93, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 9 @ ₹1736.20.
Emcure Pharmaceuticals operates within a circuit range of ₹1515.00 – ₹1851.60, with a Value of ₹19.89 CR. The Delivery Percentage for the day is 47.27%. Additionally, Emcure Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Emcure Pharmaceuticals Fundamentals
P/E Ratio
35.58
P/B Ratio
6.64
Div. Yield
0.21
Sector P/E
71.51
Sector P/B
3.05
Sec. Div. Yield
0.54
Emcure Pharmaceuticals Resistance and Support
Pivot 1703.6
Resistance
First Resistance
1727.2
Second Resistance
1771.1
Third Resistance
1794.7
Support
First Support
1659.7
Second Support
1636.1
Third Support
1592.2
Emcure Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-05 | Audited Results & Final Dividend |
| 2026-02-04 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-06 | Quarterly Results |
Emcure Pharmaceuticals News
Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Emcure Pharmaceuticals is scheduled to participate in four investor conferences in Mumbai from May 26 to June 09, 2026. The company will engage with institutional investors from Ambit Capital, 360 ONE Capital, Axis Capital, and ICICI Securities.
May 20 2026 16:55:14
Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Emcure Pharmaceuticals is scheduled to participate in four investor conferences in Mumbai from May 26 to June 09, 2026. The company will engage with institutional investors from Ambit Capital, 360 ONE Capital, Axis Capital, and ICICI Securities.
May 20 2026 16:51:37
Read More
Emcure Pharmaceuticals Management
| Name | Position |
|---|---|
| Berjis Desai | Chairman |
| Satish Mehta | Managing Director & Chief Executive Officer |
Emcure Pharmaceuticals Similar Stocks
Gland Pharma Ltd.
2262.20
-44.30 (1.92%)
Glaxosmithkline Pharmaceuticals Ltd.
2121.50
18.30 (0.87%)
JB Chemicals & Pharmaceuticals Ltd.
2257.70
5.00 (0.22%)
Global Health Ltd.
1235.10
6.00 (0.49%)
Krishna Institute of Medical Sciences Ltd
785.10
19.70 (2.57%)
Wockhardt Ltd.
1938.00
14.20 (0.74%)
Dr. Lal Pathlabs Ltd.
1601.50
8.00 (0.50%)
Acutaas Chemicals Ltd.
3145.30
17.20 (0.55%)
Sai Life Sciences Ltd.
1218.10
36.90 (3.12%)
Emcure Pharmaceuticals FAQs
The Buying Price of Emcure Pharmaceuticals share is 1736.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Emcure Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Emcure Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Emcure Pharmaceuticals shares is 35.58. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Emcure Pharmaceuticals shares is 6.64. Useful to assess the stock's value relative to its book value.
To assess Emcure Pharmaceuticals’s valuation compare Sector P/E, P/B which are 71.51 & 3.05 with sector averages, along with growth rates and financial metrics.
The Market Cap of Emcure Pharmaceuticals is 32916.54 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Emcure Pharmaceuticals share price is 1830.00 & 1228.90. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Emcure Pharmaceuticals belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
